{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:49:41Z","timestamp":1790624981622,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The question as to whether or not diabetes mellitus increases the risk of idiopathic pulmonary fibrosis (IPF) remains controversial. This study aimed to investigate the causal association between type 1 diabetes (T1D), type 2 diabetes (T2D), and IPF using Mendelian randomization (MR) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used two-sample univariate and multivariate MR (MVMR) analyses to investigate the causal relationship between T1D or T2D and IPF. We obtained genome-wide association study (GWAS) data for T1D and T2D from the European Bioinformatics Institute, comprising 29,652 T1D samples and 101,101 T1D single nucleotide polymorphisms (SNPs) and 655,666 T2D samples and 5,030,727 T2D SNPs. We also used IPF GWAS data from the FinnGen Biobank comprising 198,014 IPF samples and 16,380,413 IPF SNPs. All cases and controls in these datasets were derived exclusively from European populations. In the univariate MR analysis, we employed inverse variance-weighted (IVW), weighted median (WM), and MR-Egger regression methods. For the MVMR analysis, we used the multivariate IVW method primarily, and supplemented it with multivariate MR-Egger and multivariate MR- least absolute shrinkage and selection operator methods. Heterogeneity tests were conducted using the MR-IVW and MR-Egger regression methods, whereas pleiotropic effects were assessed using the MR-Egger intercept. The results of MR and sensitivity analyses were visualized using forest, scatter, leave-one-out, and funnel plots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Univariate MR revealed a significant causal relationship between T1D and IPF (OR\u2009=\u20091.118, 95% CI\u2009=\u20091.021\u20131.225,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016); however, no significant causal relationship was found between T2D and IPF (OR\u2009=\u20090.911, 95% CI\u2009=\u20090.796\u20131.043,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.178). MVMR analysis further confirmed a causal association between T1D and IPF (OR\u2009=\u20091.133, 95% CI\u2009=\u20091.011\u20131.270,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032), but no causal relationship between T2D and IPF (OR\u2009=\u20091.009, 95% CI\u2009=\u20090.790\u20131.288,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.950). Sensitivity analysis results validated the stability and reliability of our findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Univariate and multivariate analyses demonstrated a causal relationship between T1D and IPF, whereas no evidence was found to support a causal relationship between T2D and IPF. Therefore, in clinical practice, patients with T1D should undergo lung imaging for early detection of IPF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-024-02961-7","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T23:01:38Z","timestamp":1710889298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomization study"],"prefix":"10.1186","volume":"24","author":[{"given":"Quou","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"issue":"9","key":"2961_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2961_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):197.","journal-title":"Respir Res"},{"key":"2961_CR3","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Reviews Disease Primers. 2017;3:17074.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"2961_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2961_CR5","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s11739-021-02651-w","volume":"16","author":"A Caminati","year":"2021","unstructured":"Caminati A, Madotto F, Conti S, Cesana G, Mantovani L, Harari S. The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities. Intern Emerg Med. 2021;16(7):1793\u2013802.","journal-title":"Intern Emerg Med"},{"issue":"Suppl 1","key":"2961_CR6","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19\u201340.","journal-title":"Diabetes Care"},{"issue":"2suppl","key":"2961_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2047487319881021","volume":"26","author":"E Standl","year":"2019","unstructured":"Standl E, Khunti K, Hansen TB, Schnell O. The global epidemics of diabetes in the 21st century: current situation and perspectives. Eur J Prev Cardiol. 2019;26(2suppl):7\u201314.","journal-title":"Eur J Prev Cardiol"},{"issue":"Suppl 1","key":"2961_CR8","first-page":"S13","volume":"42","author":"2","year":"2019","unstructured":"2. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13\u201328.","journal-title":"Diabetes Care"},{"issue":"11","key":"2961_CR9","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1210\/clinem\/dgab553","volume":"106","author":"C Li","year":"2021","unstructured":"Li C, Xiao Y, Hu J, Hu Z, Yan J, Zhou Z, et al. Associations between Diabetes and Idiopathic Pulmonary Fibrosis: a study-level pooled analysis of 26 million people. J Clin Endocrinol Metab. 2021;106(11):3367\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"2961_CR10","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical Res ed). 2018;362:k601.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"7","key":"2961_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543\u201352.","journal-title":"Eur J Epidemiol"},{"key":"2961_CR12","first-page":"n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical Res ed). 2021;375:n2233.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"4","key":"2961_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"2961_CR14","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","volume":"9","author":"A Xue","year":"2018","unstructured":"Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.","journal-title":"Nat Commun"},{"issue":"19","key":"2961_CR15","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","volume":"378","author":"DJ Lederer","year":"2018","unstructured":"Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378(19):1811\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"2961_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"2961_CR17","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1378\/chest.123.6.2007","volume":"123","author":"T Enomoto","year":"2003","unstructured":"Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest. 2003;123(6):2007\u201311.","journal-title":"Chest"},{"issue":"2","key":"2961_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.rmed.2009.08.013","volume":"104","author":"MC Garc\u00eda-Sancho Figueroa","year":"2010","unstructured":"Garc\u00eda-Sancho Figueroa MC, Carrillo G, P\u00e9rez-Padilla R, Fern\u00e1ndez-Plata MR, Buend\u00eda-Rold\u00e1n I, Vargas MH, et al. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study. Respir Med. 2010;104(2):305\u20139.","journal-title":"Respir Med"},{"issue":"6","key":"2961_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.rmed.2008.11.001","volume":"103","author":"J Gribbin","year":"2009","unstructured":"Gribbin J, Hubbard R, Smith C. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med. 2009;103(6):927\u201331.","journal-title":"Respir Med"},{"issue":"7","key":"2961_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1513\/AnnalsATS.201412-553OC","volume":"12","author":"HR Collard","year":"2015","unstructured":"Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, et al. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. Annals Am Thorac Soc. 2015;12(7):981\u20137.","journal-title":"Annals Am Thorac Soc"},{"issue":"12","key":"2961_CR21","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.rmed.2011.08.022","volume":"105","author":"C Garc\u00eda-Sancho","year":"2011","unstructured":"Garc\u00eda-Sancho C, Buend\u00eda-Rold\u00e1n I, Fern\u00e1ndez-Plata MR, Navarro C, P\u00e9rez-Padilla R, Vargas MH, et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med. 2011;105(12):1902\u20137.","journal-title":"Respir Med"},{"key":"2961_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.diabres.2018.05.029","volume":"142","author":"C George","year":"2018","unstructured":"George C, Ducatman AM, Conway BN. Increased risk of respiratory diseases in adults with type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2018;142:46\u201355.","journal-title":"Diabetes Res Clin Pract"},{"key":"2961_CR23","doi-asserted-by":"crossref","unstructured":"Jeganathan N, Miot C, Sathananthan A, Sathananthan M. The association of pulmonary fibrosis with diabetes mellitus. ERJ open Res. 2020;6(4).","DOI":"10.1183\/23120541.00237-2020"},{"issue":"2","key":"2961_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/imj.15191","volume":"51","author":"V Navaratnam","year":"2021","unstructured":"Navaratnam V, Davis TME, Hubbard R, Davis WA. Incidence and predictors of idiopathic pulmonary fibrosis complicating type 2 diabetes: the Fremantle Diabetes Study Phase I. Intern Med J. 2021;51(2):276\u20139.","journal-title":"Intern Med J"},{"issue":"206","key":"2961_CR25","doi-asserted-by":"publisher","first-page":"206ra139","DOI":"10.1126\/scitranslmed.3006998","volume":"5","author":"AK Shum","year":"2013","unstructured":"Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, et al. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci Transl Med. 2013;5(206):206ra139.","journal-title":"Sci Transl Med"},{"issue":"5","key":"2961_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1183\/09031936.00069307","volume":"30","author":"TM Maher","year":"2007","unstructured":"Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J. 2007;30(5):835\u20139.","journal-title":"Eur Respir J"},{"issue":"1","key":"2961_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08916930701619169","volume":"41","author":"CE Taplin","year":"2008","unstructured":"Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41(1):11\u20138.","journal-title":"Autoimmunity"},{"issue":"10","key":"2961_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/resp.14543","volume":"28","author":"D Kalafatis","year":"2023","unstructured":"Kalafatis D, Joshua V, Hansson M, Mathsson-Alm L, Hensvold A, Sk\u00f6ld M. Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosis. Respirol (Carlton Vic). 2023;28(10):925\u201333.","journal-title":"Respirol (Carlton Vic)"},{"issue":"7562","key":"2961_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523(7562):612\u20136.","journal-title":"Nature"},{"issue":"1","key":"2961_CR30","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s41467-022-29512-0","volume":"13","author":"ML Yang","year":"2022","unstructured":"Yang ML, Horstman S, Gee R, Guyer P, Lam TT, Kanyo J, et al. Citrullination of glucokinase is linked to autoimmune diabetes. Nat Commun. 2022;13(1):1870.","journal-title":"Nat Commun"},{"issue":"11","key":"2961_CR31","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2337\/db18-0295","volume":"67","author":"M Buitinga","year":"2018","unstructured":"Buitinga M, Callebaut A, Marques C\u00e2mara Sodr\u00e9 F, Cr\u00e8vecoeur I, Blahnik-Fagan G, Yang ML, et al. Inflammation-Induced Citrullinated glucose-regulated protein 78 elicits Immune responses in human type 1 diabetes. Diabetes. 2018;67(11):2337\u201348.","journal-title":"Diabetes"},{"issue":"6","key":"2961_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2337\/dbi17-0030","volume":"67","author":"EA James","year":"2018","unstructured":"James EA, Pietropaolo M, Mamula MJ. Immune Recognition of \u03b2-Cells: neoepitopes as key players in the loss of Tolerance. Diabetes. 2018;67(6):1035\u201342.","journal-title":"Diabetes"},{"issue":"12","key":"2961_CR33","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JA Babon","year":"2016","unstructured":"Babon JA, DeNicola ME, Blodgett DM, Cr\u00e8vecoeur I, Buttrick TS, Maehr R, et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med. 2016;22(12):1482\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"2961_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12931-017-0692-9","volume":"18","author":"KD Samara","year":"2017","unstructured":"Samara KD, Trachalaki A, Tsitoura E, Koutsopoulos AV, Lagoudaki ED, Lasithiotaki I, et al. Upregulation of citrullination pathway: from autoimmune to idiopathic lung fibrosis. Respir Res. 2017;18(1):218.","journal-title":"Respir Res"},{"issue":"4","key":"2961_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/path.1439","volume":"200","author":"EC Tsilibary","year":"2003","unstructured":"Tsilibary EC. Microvascular basement membranes in diabetes mellitus. J Pathol. 2003;200(4):537\u201346.","journal-title":"J Pathol"},{"issue":"11","key":"2961_CR36","doi-asserted-by":"publisher","first-page":"e103477","DOI":"10.15252\/embj.2019103477","volume":"39","author":"V Kumar","year":"2020","unstructured":"Kumar V, Agrawal R, Pandey A, Kopf S, Hoeffgen M, Kaymak S, et al. Compromised DNA repair is responsible for diabetes-associated fibrosis. EMBO J. 2020;39(11):e103477.","journal-title":"EMBO J"},{"issue":"12","key":"2961_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41574-021-00577-z","volume":"17","author":"V Kumar","year":"2021","unstructured":"Kumar V, Nawroth PP. Is the association between diabetes mellitus and pulmonary fibrosis real? Nat Reviews Endocrinol. 2021;17(12):703\u20134.","journal-title":"Nat Reviews Endocrinol"},{"key":"2961_CR38","doi-asserted-by":"crossref","unstructured":"Gamad N, Malik S, Suchal K, Vasisht S, Tomar A, Arava S, et al. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: pharmacological effects and molecular mechanisms. Volume 97. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine &; 2018. pp. 1544\u201353. pharmacotherapie.","DOI":"10.1016\/j.biopha.2017.11.101"},{"issue":"8","key":"2961_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan S, Bone NB, Zmijewska AA, Jiang S, Park DW, Bernard K, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"2961_CR40","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1038\/s41598-020-74912-1","volume":"10","author":"J Fandi\u00f1o","year":"2020","unstructured":"Fandi\u00f1o J, Toba L, Gonz\u00e1lez-Mat\u00edas LC, Diz-Chaves Y, Mallo F. GLP-1 receptor agonist ameliorates experimental lung fibrosis. Sci Rep. 2020;10(1):18091.","journal-title":"Sci Rep"},{"issue":"1","key":"2961_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3892\/etm.2017.4555","volume":"14","author":"W Yu","year":"2017","unstructured":"Yu W, Mi L, Long T. Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats. Experimental Therapeutic Med. 2017;14(1):609\u201315.","journal-title":"Experimental Therapeutic Med"},{"key":"2961_CR42","doi-asserted-by":"crossref","unstructured":"El-Horany HE, Atef MM, Abdel Ghafar MT, Fouda MH, Nasef NA, Hegab II et al. Empagliflozin ameliorates Bleomycin-Induced Pulmonary fibrosis in rats by modulating Sesn2\/AMPK\/Nrf2 signaling and targeting ferroptosis and autophagy. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119481"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02961-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-02961-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02961-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T23:01:53Z","timestamp":1710889313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-02961-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2961"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-02961-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study relied solely on published GWAS datasets, and all original studies obtained appropriate ethical approval and consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}